MedPath

Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations

Not Applicable
Completed
Conditions
Colorectal Cancer
Interventions
Other: I2
Other: Health Education
Registration Number
NCT03100461
Lead Sponsor
University of Kansas Medical Center
Brief Summary

The goal of this study is to find the best ways to increase colorectal cancer (CRC) screening.

Detailed Description

Colorectal Cancer is preventable and curable but is still the second most common cause of cancer death in the U.S. Minorities and those with low income have more CRC than middle and high income Whites.. They also get fewer CRC screening tests. Low knowledge of CRC screening may, in part, drive this lower test use. We need new ways to improve CRC screening in primary care clinics where many minority and uninsured patients receive health care.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Have a home address and access to a working telephone
  • Pass Mini-Cog assessment
Exclusion Criteria
  • FIT (fecal immunochemical test) test within 1 year, Sigmoidoscopy or Barium enema within 5 years, or Colonoscopy within 10 years
  • Acute medical illness,
  • current GI bleed
  • history of adenomatous polyps
  • Colorectal Cancer
  • 1st degree relative with CRC < age 60 years
  • inherited polyposis/non-polyposis syndrome
  • inflammatory bowel disease
  • Another household member enrolled in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
I2 + HEHealth EducationParticipants receive up to two interventions. Participants receive I2 initially and then HE if not screened after 6 months.
HE + I2Health EducationParticipants receive up to two interventions. Participants receive HE initially and then I2 if not screened after 6 months.
I2 + HEI2Participants receive up to two interventions. Participants receive I2 initially and then HE if not screened after 6 months.
HE + HEHealth EducationParticipants receive up to two interventions. Participants receive HE initially and then a second time if not screened after 6 months.
HE + I2I2Participants receive up to two interventions. Participants receive HE initially and then I2 if not screened after 6 months.
I2 + I2I2Participants receive up to two interventions. Participants receive I2 initially and then a second time if not screened after 6 months.
Primary Outcome Measures
NameTimeMethod
CRC screening completion rate12-14 Months

Rate of participants who receive CRC screening during study participation

Secondary Outcome Measures
NameTimeMethod
Cost analysis of each intervention pathway14 Months

Measure will be calculated by estimating all cost factors in the CRC screening process, include personnel and materials/supplies costs, materials development costs, and time of all study staff involved. Measure represented as a per participant cost to complete screening.

Trial Locations

Locations (1)

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath